Four FDA guidances related to DSCSA awaiting OMB sign-off
Regulatory NewsJoanne S. Eglovitch
ComplianceNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyRegulatory NewsJoanne S. EglovitchComplianceNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy